Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001083381) titled 'ACE2.0 Hearing Program: Evaluating a Group-Based Communication and Wellbeing Intervention for Adults with Hearing Loss and Their Families' on Sept. 2.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: University of Queensland
Condition:
Hearing Loss
Hearing Loss
Ear - Deafness
Intervention:
Intervention Formats and Delivery Schedule - the difference in the arms is the number of sessions only. Arm 2 will therefore cover all modules, whilst Arm1 will cover on...